Literature DB >> 9891091

Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex.

E Chu1, S M Copur, J Ju, T M Chen, S Khleif, D M Voeller, N Mizunuma, M Patel, G F Maley, F Maley, C J Allegra.   

Abstract

A thymidylate synthase (TS)-ribonucleoprotein (RNP) complex composed of TS protein and the mRNA of the tumor suppressor gene p53 was isolated from cultured human colon cancer cells. RNA gel shift assays confirmed a specific interaction between TS protein and the protein-coding region of p53 mRNA, and in vitro translation studies demonstrated that this interaction resulted in the specific repression of p53 mRNA translation. To demonstrate the potential biological role of the TS protein-p53 mRNA interaction, Western immunoblot analysis revealed nearly undetectable levels of p53 protein in TS-overexpressing human colon cancer H630-R10 and rat hepatoma H35(F/F) cell lines compared to the levels in their respective parent H630 and H35 cell lines. Polysome analysis revealed that the p53 mRNA was associated with higher-molecular-weight polysomes in H35 cells compared to H35(F/F) cells. While the level of p53 mRNA expression was identical in parent and TS-overexpressing cell lines, the level of p53 RNA bound to TS in the form of RNP complexes was significantly higher in TS-overexpressing cells. The effect of TS on p53 expression was also investigated with human colon cancer RKO cells by use of a tetracycline-inducible system. Treatment of RKO cells with a tetracycline derivative, doxycycline, resulted in 15-fold-induced expression of TS protein and nearly complete suppression of p53 protein expression. However, p53 mRNA levels were identical in transfected RKO cells in the absence and presence of doxycycline. Taken together, these findings suggest that TS regulates the expression of p53 at the translational level. This study identifies a novel pathway for regulating p53 gene expression and expands current understanding of the potential role of TS as a regulator of cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9891091      PMCID: PMC116086          DOI: 10.1128/MCB.19.2.1582

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

Review 1.  p53 function and dysfunction.

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

Review 2.  The p53 tumor suppressor protein, a modulator of cell proliferation.

Authors:  S J Ullrich; C W Anderson; W E Mercer; E Appella
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

3.  The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency.

Authors:  D R Gallie
Journal:  Genes Dev       Date:  1991-11       Impact factor: 11.361

Review 4.  Structural features in eukaryotic mRNAs that modulate the initiation of translation.

Authors:  M Kozak
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

Review 5.  Do the poly(A) tail and 3' untranslated region control mRNA translation?

Authors:  R J Jackson; N Standart
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue.

Authors:  P G Johnston; C M Liang; S Henry; B A Chabner; C J Allegra
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

7.  Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.

Authors:  E Chu; S Zinn; D Boarman; C J Allegra
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

8.  Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Authors:  E Chu; D M Koeller; J L Casey; J C Drake; B A Chabner; P C Elwood; S Zinn; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

Review 10.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

View more
  32 in total

1.  Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique.

Authors:  S A Brooks; W F Rigby
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Prognostic significance of miR-215 in colon cancer.

Authors:  Mihriban Karaayvaz; Timothy Pal; Bo Song; Cecilia Zhang; Penelope Georgakopoulos; Saira Mehmood; Stephanie Burke; Kenneth Shroyer; Jingfang Ju
Journal:  Clin Colorectal Cancer       Date:  2011-07-12       Impact factor: 4.481

Review 3.  p53 RNA interactions: new clues in an old mystery.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

4.  MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.

Authors:  Xiang Sun; Longhua Lou; Kezhao Zhong; Lijuan Wan
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-21

5.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

Review 6.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

Review 7.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

8.  Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip).

Authors:  Kenji Kudo; Yaguang Xi; Yuan Wang; Bo Song; Edward Chu; Jingyue Ju; James J Russo; Jingfang Ju
Journal:  Nucleic Acids Res       Date:  2010-01-31       Impact factor: 16.971

9.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Authors:  Bo Song; Yuan Wang; Matthew A Titmus; Galina Botchkina; Andrea Formentini; Marko Kornmann; Jingfang Ju
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

Review 10.  Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?

Authors:  F Gieseler; P Rudolph; G Kloeppel; U R Foelsch
Journal:  Int J Colorectal Dis       Date:  2003-05-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.